Clinical trials in cardiology are systematic investigations conducted to evaluate the safety, efficacy, and effectiveness of new treatments, interventions, or therapeutic strategies for cardiovascular conditions. These trials are essential for advancing medical knowledge, improving patient care, and informing evidence-based practices in cardiology. Various phases of clinical trials are conducted, starting with early-phase trials to assess safety and dosage, followed by larger, randomized controlled trials that aim to establish the efficacy of the intervention. Cardiology clinical trials often focus on diverse areas, including the development of new medications, evaluation of interventional procedures such as stent placement or cardiac surgeries, and investigation of innovative technologies like implantable devices. Participation in clinical trials allows patients access to cutting-edge treatments and contributes valuable data to the scientific community, shaping the future of cardiovascular medicine.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom